JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/joe.0.1690361

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, C
Right arrow Articles by Jarry, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, C
Right arrow Articles by Jarry, H
Journal of Endocrinology, Vol 169, Issue 2, 361-371
Copyright © 2001 by Society for Endocrinology


Articles

Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model

C Roth, M Schricker, M Lakomek, A Strege, I Heiden, H Luft, U Munzel, W Wuttke, and H Jarry


To address whether gonadotropin-releasing hormone (GnRH) regulates its own expression and the expression of its receptor in the hypothalamus and ovary, we treated five groups of prepubertal/peripubertal female rats from postnatal days 25-36 with either the GnRH agonist triptorelin (TRIP) or the GnRH antagonist cetrorelix (CET), each 10 or 100 microgram/day, or a placebo. We compared their effects regarding pubertal development, serum gonadotropins and the expression of GnRH and GnRH-receptor in the hypothalamus, pituitary, ovary and uterus. Onset of puberty was determined by vaginal opening, and expression levels of GnRH and GnRH-receptor were determined using either quantitative real-time PCR or competitive RT-PCR. Onset of puberty was retarded by both analogs but CET (100 microgram/day) inhibited while TRIP (10 and 100 microgram/day) stimulated serum gonadotropins (P<0.05). The expression of GnRH in the preoptic area did not show significant differences among the treatment groups but ovarian GnRH mRNA levels were significantly stimulated by CET (100 microgram/day). GnRH mRNA could not be detected in the uterus by either real-time PCR or competetive RT-PCR. The GnRH-receptor expression in the hypothalamus (preoptic area and mediobasal hypothalamus) did not vary among any of the groups, whereas in the pituitary GnRH-receptor mRNA levels were stimulated by TRIP (10 microgram/day) but inhibited by CET (100 microgram/day). In contrast, in the ovary GnRH-receptor mRNA levels were inhibited by both TRIP (100 microgram/day) and CET (100 microgram/day). Interestingly, the GnRH-receptor was even expressed in the uterus where it was strongly stimulated by both CET and TRIP in a dose-related manner. This shows that in addition to their different pituitary effects, the GnRH analogs cetrorelix and triptorelin exert different actions at the hypothalamic, ovarian and uterine level. This study also demonstrates an organ-specific regulation of GnRH and GnRH-receptor gene expression which is likely part of a local autoregulatory system. We conclude that the ovarian and uterine effects of GnRH analogs must be considered in addition to their known pituitary effects when deciding which GnRH analog is most suitable for treating precocious puberty.


This article has been cited by other articles:


Home page
JCBHome page
J. Prange-Kiel, H. Jarry, M. Schoen, P. Kohlmann, C. Lohse, L. Zhou, and G. M. Rune
Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesis
J. Cell Biol., January 28, 2008; 180(2): 417 - 426.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. L. Baldwin, I. N. Wegorzewska, M. Flora, and T. J. Wu
Regulation of Type II Luteinizing Hormone-Releasing Hormone (LHRH-II) Gene Expression by the Processed Peptide of LHRH-I, LHRH-(1-5) in Endometrial Cells
Experimental Biology and Medicine, January 1, 2007; 232(1): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Bottner, J. Christoffel, H. Jarry, and W. Wuttke
Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats.
J. Endocrinol., April 1, 2006; 189(1): 77 - 88.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J Christoffel, G Rimoldi, and W Wuttke
Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment.
J. Endocrinol., March 1, 2006; 188(3): 397 - 405.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. D. Schirman-Hildesheim, T. Bar, N. Ben-Aroya, and Y. Koch
Differential Gonadotropin-Releasing Hormone (GnRH) and GnRH Receptor Messenger Ribonucleic Acid Expression Patterns in Different Tissues of the Female Rat across the Estrous Cycle
Endocrinology, August 1, 2005; 146(8): 3401 - 3408.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Wu, S. K. Mani, M. J. Glucksman, and J. L. Roberts
Stimulation of Luteinizing Hormone-Releasing Hormone (LHRH) Gene Expression in GT1-7 Cells by Its Metabolite, LHRH-(1-5)
Endocrinology, January 1, 2005; 146(1): 280 - 286.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
C A Herbert, T E Trigg, and D W Cooper
Effect of deslorelin implants on follicular development, parturition and post-partum oestrus in the tammar wallaby (Macropus eugenii)
Reproduction, February 1, 2004; 127(2): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Zapatero-Caballero, F. Sanchez-Franco, C. Fernandez-Mendez, M. Garcia-San Frutos, L. M. Botella-Cubells, and G. Fernandez-Vazquez
Gonadotropin-Releasing Hormone Receptor Gene Expression During Pubertal Development of Female Rats
Biol Reprod, February 1, 2004; 70(2): 348 - 355.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kovacs and A. V. Schally
Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats
PNAS, October 9, 2001; 98(21): 12197 - 12202.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Endocrinology.